The latest research study “Hydroxyapatite Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global hydroxyapatite market size reached US$ 2.27 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.19 Billion by 2027, exhibiting a growth rate (CAGR) of 5.70% during 2022-2027.
Hydroxyapatite (Ca10(PO4)6(OH)2) represents a naturally occurring inorganic calcium phosphate mineral that is synthesized from numerous biological sources, including mammalian bone, fish scales, eggshells, etc. It is similar to hard tissue in morphology as well as composition and has a hexagonal structure and serum calcium to phosphorous (Ca/P) ratio identical to bone apatite. Unlike calcium phosphates, hydroxyapatite can remain thermodynamically stable under several temperature and pH levels. Hydroxyapatite offers high rigidity, better enamel remineralization than saliva, faster bone healing at the bone-implant interface, compositional closeness to bone minerals, etc. Consequently, it is extensively used in coatings to coarsen metal implant surfaces, bone grafts or fillers, orthopedic and dental care devices, etc. Presently, hydroxyapatite is commonly bifurcated into nano and micro-sized types.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a free sample brochure: https://www.imarcgroup.com/hydroxyapatite-market/requestsample
Hydroxyapatite Market Trends and Drivers:
The growing prevalence of cardiovascular diseases (CVDs) and the inflating requirement for bone grafting, transplants, bioactive ceramics, etc., are among the key factors stimulating the hydroxyapatite market. Apart from this, the increasing consumer consciousness towards their physical appearance and the rising incidents of dermatological issues, especially among the geriatric population, are acting as significant growth-inducing factors. Moreover, the widespread adoption of nano-hydroxyapatite in drug and gene delivery, bone tissue engineering and fillers, and as a desensitizing agent to decrease tooth sensitivity and reduce plaque levels for teeth whitening is positively influencing the global market. Besides this, various benefits associated with hydroxyapatite, such as bioactivity, osteoconductive, non-toxicity, and non-inflammatory properties, are also propelling the market growth. Furthermore, it is gaining extensive popularity as a fluoride substitute, which is expected to fuel the hydroxyapatite market over the forecasted period.
Hydroxyapatite Market Report Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
APS Materials Inc., Berkeley Advanced Biomaterials, Bio-Rad Laboratories Inc., CAM Bioceramics B.V., Cgbio, Fluidinova S.A., HOYA Technosurgical Corporation (Hoya Corporation), Medtronic plc, Merz Pharma GmbH & Co. KGaA, SigmaGraft Biomaterials, SofSera Corporation, Taihei Chemical Industrial Co. Ltd. and Zimmer Biomet.
The report has been segmented the market into following categories:
Breakup by Type:
- Greater than Micrometer
Breakup by Application:
- Dental Care
- Plastic Surgery
Click here to view detailed information with table of content: https://www.imarcgroup.com/hydroxyapatite-market
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800